Trial · NCT02293395
Adverse events352
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 352
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Chest Pain | General disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 11 | 1,510 | |
| other | Chest Pain | General disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 19 | 1,506 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 16 | 1,510 | |
| other | Cough | Respiratory, thoracic and mediastinal disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 14 | 1,506 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 33 | 1,510 | |
| other | Dyspnoea | Respiratory, thoracic and mediastinal disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 39 | 1,506 | |
| other | Hypertension | Vascular disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 23 | 1,510 | |
| other | Hypertension | Vascular disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 22 | 1,506 | |
| serious | Anaemia | Blood and lymphatic system disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 1 | 1,510 | |
| serious | Anaemia | Blood and lymphatic system disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 0 | 1,506 | |
| serious | Acute Left Ventricular Failure | Cardiac disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 3 | 1,510 | |
| serious | Acute Left Ventricular Failure | Cardiac disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 0 | 1,506 | |
| serious | Acute Myocardial Infarction | Cardiac disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 1 | 1,510 | |
| serious | Acute Myocardial Infarction | Cardiac disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 0 | 1,506 | |
| serious | Angina Pectoris | Cardiac disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 0 | 1,510 | |
| serious | Angina Pectoris | Cardiac disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 2 | 1,506 | |
| serious | Angina Unstable | Cardiac disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 5 | 1,510 | |
| serious | Angina Unstable | Cardiac disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 5 | 1,506 | |
| serious | Aortic Valve Stenosis | Cardiac disorders | Rivaroxaban 2.5 mg Twice Daily (BID) | 1 | 1,510 | |
| serious | Aortic Valve Stenosis | Cardiac disorders | Acetylsalicylic Acid 100 mg Once Daily (OD) | 0 | 1,506 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02293395/events